While immunotherapies have shown great promise in treating blood cancers, most clinical trials aimed at treating solid tumors such as pancreatic or lung cancer have failed. Researchers have long thought that solid tumors' ...
Sep 18, 2023
0
138
A new study published in Science Advances has investigated one of the still poorly understood aspects of cancer, therapy-induced senescence in tumor cells. The study, the result of collaboration between researchers from Politecnico ...
Sep 14, 2023
0
28
A new study has shed light on why immunotherapy does not always work in certain types of cancer. Led by researchers at EMBL's European Bioinformatics Institute (EMBL-EBI), Cold Spring Harbor Laboratory (CSHL), and the Massachusetts ...
Sep 14, 2023
0
25
The vertebral bones that form the spine are derived from a distinct type of stem cell that secretes a protein favoring tumor metastases, according to a study led by researchers at Weill Cornell Medicine. The discovery opens ...
Sep 13, 2023
0
23
Scientists from the German Cancer Research Center (DKFZ) identify a new and surprising function of a membrane protein on the surface of cancer cells: It supports and stabilizes an important "co-stimulatory" factor that enhances ...
Sep 13, 2023
0
79
In recent years, cancer researchers have hailed the arrival of chimeric antigen receptor T cell (CAR T) therapy, which has delivered promising results, transforming the fight against various forms of cancer. The process involves ...
Sep 13, 2023
0
26
Reflux disease manifests as acid regurgitation and heartburn and is a known risk factor for esophageal cancer. However, a new study published in The BMJ by researchers at Karolinska Institutet now reports that the majority ...
Sep 13, 2023
0
48
Through study findings published in Cell Reports, a team of scientists at VCU Massey Cancer Center has discovered a previously unknown interaction between proteins that is responsible for supplying energy to tumor cells and ...
Sep 12, 2023
0
72
A research team led by Shir Filo and Prof. Aviv Mezer of the Safra Center for Brain Science at the Hebrew University of Jerusalem (ELSC) and Dr. Tal Shahar, currently Director of the Neurosurgical Oncology Unit at the Neurosurgery ...
Sep 12, 2023
0
35
The discovery of a previously unknown molecular target has inspired what may become a therapeutic breakthrough for people with glioblastoma, the most common and aggressive brain cancer.
Sep 11, 2023
0
92
